BEUDAMED
    FDA PMA FDA Class 3 Approved 🇺🇸 United States

    Stent, Superficial Femoral Artery, Drug-Eluting

    PMA: P180011 · Supplement: S024 · Decision Apr 1, 2020
    View on FDA
    Classifications
    1
    FEI Numbers
    9
    Registration Numbers
    9

    Basic Information

    Device Name
    Stent, Superficial Femoral Artery, Drug-Eluting
    Trade Name
    Eluvia Drug-Eluting Vascular Stent System
    PMA Number
    P180011
    Supplement Number
    S024
    Device Class
    FDA Class 3
    Product Code
    NIU
    Generic Name
    Stent, superficial femoral artery, drug-eluting
    Medical Specialty
    Unknown
    Advisory Committee
    Cardiovascular
    Decision
    Approved
    Decision Code
    APPR
    Decision Date
    April 1, 2020
    Date Received
    January 21, 2020
    Supplement Type
    Normal 180 Day Track No User Fee
    Supplement Reason
    Postapproval Study Protocol
    Expedited Review
    N

    Advisory Committee Statement

    Approval for the revised protocols for the post-approval studies (PAS) protocol, including terminating enrollment in the REGAL study and extending follow-up to five years for the EMINENT study.

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    NIU Stent, Superficial Femoral Artery, Drug-Eluting